The GPHF-Minilab® - Focusing on Prevalent Medicines against Infectious Diseases
The GPHF-Minilab focuses its work on a range of 63 drug compounds instantly life-threatened when diluted down to nothing. They have been selected on the basis of prevailing prescription practices, public health interest and existing counterfeit case reports, the current short list consisting of common antimicrobials, anthelminthics, anti(retro)virals, antimalarials, antituberculosis and some other medicines including their appropriate fixed-dose combination products. The list is regularly extended.
| Antimicrobials | Amoxicillin | | Ampicillin | | Azithromycin | | Cefalexin | | Cefixime | | Cefuroxime | | Chloramphenicol | | Ciprofloxacin | | Clarithromycin | | Clavulanic acid | | Cloxacillin | | Erythromycin | | Levofloxacin | | Metronidazole | | Moxifloxacin | | Ofloxacin | | Phenoxymethylpenicillin | | Sulfamethoxazole | | Tetracycline | | Trimethoprim | | | | | Antimalarials | Amodiaquine | | Artemether | | Artesunate | | Atovaquone | | Chloroquine | | Dihydroartemisinin | | Halofantrine | | Lumefantrine | | Mefloquine | | Piperaquine | | Primaquine | | Proguanil | | Pyrimethamine | | Pyronaridine | | Quinine | | Sulfadoxine | | Sulfamethoxypyrazine | | | | | Antituberculosis medicines | Ciprofloxacin | | Cycloserine | | Ethambutol | | Ethionamide | | Isoniazid | | Kanamycin | | Levofloxacin | | Moxifloxacin | | Ofloxacin | | Prothionamide | | Pyrazinamide | | Rifampicin | | | | | Anti(retro)virals | Didanosine | | Indinavir | | Lamivudine | | Nevirapine | | Oseltamivir | | Stavudine | | Zidovudine | | | | | Anthelminthics | Albendazole | | Mebendazole | | Praziquantel | | | | | Antifungals | Griseofulvin | | | | | Non Anti-Infectives | Acetylsalicylic acid | | Aminophylline | | Furosemide | | Glibenclamide | | Paracetamol | | Prednisolone | | Salbutamol | | | |
|